Literature DB >> 9726961

Activation of caspase-1 in the nucleus requires nuclear translocation of pro-caspase-1 mediated by its prodomain.

P L Mao1, Y Jiang, B Y Wee, A G Porter.   

Abstract

The interleukin-1beta-converting enzyme-like protease precursor, pro-caspase-1, has an N-terminal prodomain that is removed during cleavage activation of the protease. Here we show that tumor necrosis factor treatment of HeLa cells induced apoptosis without detectable proteolytic activation of caspase-1 in the cytosol. Instead, tumor necrosis factor induced the translocation of pro-caspase-1 to the nucleus where it was proteolytically activated, releasing the intact prodomain. We identified a nuclear localization signal in the prodomain, which was required for translocation of both pro-caspase-1 as well as its prodomain to the nucleus. Surprisingly, transfected MCF-7 carcinoma or embryonic kidney 293T cells expressing the prodomain alone underwent apoptosis. These results show that death signal-induced nuclear targeting is a novel activity of a caspase prodomain and indicate that caspase-1 and its prodomain may have hitherto unsuspected nuclear functions in apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726961     DOI: 10.1074/jbc.273.37.23621

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Subcellular localization of CrmA: identification of a novel leucine-rich nuclear export signal conserved in anti-apoptotic serpins.

Authors:  Jose A Rodriguez; Simone W Span; Frank A E Kruyt; Giuseppe Giaccone
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

2.  Rubella virus nonstructural protein protease domains involved in trans- and cis-cleavage activities.

Authors:  Y Liang; J Yao; S Gillam
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 3.  Current knowledge on procaspase-1 variants with reduced or abrogated enzymatic activity in autoinflammatory disease.

Authors:  Hella Luksch; Stefan Winkler; Michael C Heymann; Felix Schulze; Sigrun R Hofmann; Joachim Roesler; Angela Rösen-Wolff
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

Review 4.  Proteases for cell suicide: functions and regulation of caspases.

Authors:  H Y Chang; X Yang
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

5.  Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein.

Authors:  T Kawaguchi; M Takenoshita; T Kabashima; K Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

6.  p53 associates with and targets Delta Np63 into a protein degradation pathway.

Authors:  E A Ratovitski; M Patturajan; K Hibi; B Trink; K Yamaguchi; D Sidransky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

7.  Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain.

Authors:  Nicole B Bryan; Andrea Dorfleutner; Yon Rojanasakul; Christian Stehlik
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 8.  Use of fluorescently labeled caspase inhibitors as affinity labels to detect activated caspases.

Authors:  Jerzy Grabarek; Paul Amstad; Zbigniew Darzynkiewicz
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

9.  Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis.

Authors:  Birgit Ey; Annette Eyking; Magdalena Klepak; Nita H Salzman; Joachim R Göthert; Michael Rünzi; Kurt W Schmid; Guido Gerken; Daniel K Podolsky; Elke Cario
Journal:  J Immunol       Date:  2013-05-01       Impact factor: 5.422

10.  Determinants of the nuclear localization of the heterodimeric DNA fragmentation factor (ICAD/CAD).

Authors:  D Lechardeur; L Drzymala; M Sharma; D Zylka; R Kinach; J Pacia; C Hicks; N Usmani; J M Rommens; G L Lukacs
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.